“Patient-Reported Outcomes for Tirbanibulin Effectiveness and Safety in Actinic Keratosis in Real-world Settings: PROAK Study Protocol”, J of Skin, vol. 6, no. 2, p. s19, Mar. 2022, doi: 10.25251/skin.6.supp.19.